Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations
This study has been completed.
Study NCT01574898   Information provided by Pierre Fabre Medicament

First Received on April 2, 2012.   Last Updated on July 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Smokers
Interventions listed in this trial
V0474 - A mg
V0474 - B mg
V0474 - C mg
V0018 - B mg
Niquitin® Fresh Mint 4 mg
Additional drug interventions recognized in this trial
Central Nervous System Agents
Nicotine
More general drug interventions related to this trial
Autonomic Agents
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Pierre Fabre Medicament


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services